Recombinant MAP2K6 (MEK6) protein
| Aliases: Mitogen activated protein kinase kinase 6, SAPKK3, SAPKK-3, MEK6, MKK6, MAPKK6, PRKMK6, MAPK/ERK Kinase 6, SAPK Kinase, MEK |
| Catalog No: 82030 | Format: 20 µg | ¥3,920 | Add to Cart |
| Catalog No: 82630 | Format: 1 mg | ¥33,200 | Add to Cart |
Request a quote for a bulk order Request Quote
Expressed In: Baculovirus Protein Species: Human
Contents
A representative Technical Data Sheet (TDS) is provided here. Please refer to the lot-specific TDS you will receive with your order for the lot-specific buffer contents and protein concentration.
Background
MAP2K6 (Dual specificity mitogen-activated protein kinase kinase 6), also known as MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3 and SAPKK3.MAP2K6 is a dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK11 activator in response to TNF. MAP2K6/MKK6 also phosphorylates and activates PAK6. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Nuclear targets of p38 MAP kinase include the transcription factors ATF2 and ELK1. Within the p38 MAPK signal transduction pathway MAP3K6/MKK6 mediates phosphorylation of STAT4 through MAPK14 activation and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction; and for IFNG-dependent gene transcription. Has a role in osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, and in endochondral ossification and since SOX9 is another likely downstream target of the p38 MAPK pathway. MAP2K6/MKK6 mediates apoptotic cell death in thymocytes. Acts also as a regulator for melanocytes dendricity, through the modulation of Rho family GTPases.
Application Notes
This product was manufactured as described in Protein Details. Where possible, Active Motif has developed functional or activity assays for recombinant proteins. Additional characterization such as enzyme kinetic activity assays, inhibitor screening or other biological activity assays may not have been performed for every product. All available data for a given product is shown on the lot-specific Technical Data Sheet.
Protein Details
Recombinant MAP2K6 (MEK6) protein was expressed in a baculovirus expression system as the full-length protein (accession number NP_002749.2) with an N-terminal FLAG tag. The molecular weight of the protein is 38.78 kDa.
References
Human
Recombinant MAP2K6 (MEK6) protein
10% SDS-PAGE Comassie staining
MW: 38.78 kDa
Purity: >95%
Storage
Recombinant proteins in solution are temperature sensitive and must be stored at -80°C to prevent degradation. Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
Guarantee
This product is guaranteed for 6 months from date of receipt.
This product is for research use only and is not for use in diagnostic procedures.
